Lawrenceville, NJ, United States of America

Mary F Malley

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, Astrazeneca Ab, Bristol Meyers Squibb Company. Active years: 2008-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary F Malley. Retrieved from https://idiyas.com/inventor/mary-f-malley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 55.6

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 19(Granted Patents)

Location History:

Lawrenceville, NJ (US) (2008 - 2013)
Princeton, NJ (US) (2012 - 2014)

Company Filing History:

7 out of 3,742

Bristol-Myers Squibb Compnay

Bristol Meyers Squibb Company

patents

Years Active: 2008-2014

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8802715 - Crystal forms of saxagliptin and processes for preparing same (2014-08-12),

2. 8513428 - Process for preparing atazanavir bisulfate and novel forms (2013-08-20),

3. 8236847 - Crystal forms of saxagliptin and processes for preparing same (2012-08-07),

4. 7943656 - Crystal forms of saxagliptin and processes for preparing same (2011-05-17),

5. 7838678 - Process for preparing atazanavir bisulfate and novel forms (2010-11-23),

6. 7829720 - Process for preparing atazanavir bisulfate and novel forms (2010-11-09),

7. 7388096 - Crystalline forms of a factor Xa inhibitor (2008-06-17),

8. 7381737 - Crystalline forms and process for preparing spiro-hydantoin compounds (2008-06-03),

9. 7371864 - Crystalline forms of a factor Xa inhibitor (2008-05-13),

Title: Mary F Malley: Innovator in Pharmaceutical Chemistry

Introduction

Mary F Malley is a prominent inventor based in Lawrenceville, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. Her work primarily focuses on the development of novel pharmaceutical compounds and processes.

Latest Patents

Among her latest patents is the invention related to crystal forms of saxagliptin and processes for preparing the same. This patent provides physical crystal structures of a compound, including various forms and pharmaceutical compositions that can be used in treating diseases such as diabetes. Another notable patent involves a process for preparing atazanavir bisulfate, an HIV protease inhibitor. This process details the reaction of atazanavir free base with concentrated sulfuric acid to produce highly crystalline forms of the bisulfate salt.

Career Highlights

Mary F Malley has worked with leading pharmaceutical companies, including Bristol-Myers Squibb Company and AstraZeneca AB. Her expertise in pharmaceutical development has led to advancements in drug formulations and therapeutic applications.

Collaborations

Throughout her career, she has collaborated with notable professionals in the field, including Jack Z Gougoutas and Chenkou Wei. These collaborations have contributed to her innovative research and patent developments.

Conclusion

Mary F Malley is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. Her contributions continue to impact the field positively, showcasing her dedication to innovation and research.

Profile summary based on public USPTO records.